News

Thyroid tumor reclassification eases burden, raises diagnostic questions


 

FROM JAMA ONCOLOGY

References

Dr. Nikiforov is a consultant for Quest Diagnostics. A coauthor, Dr. Sylvia Asa, is a member of the medical advisory board of Leica Aperio, and another coauthor, Dr. Virginia LiVolsi, is a consultant for Veracyte Inc. The project used a facility supported by the National Cancer Institute, and molecular analysis was supported in part by funds from the University of Pittsburgh Cancer Institute and the University of Pittsburgh Medical Center. The Endocrine Pathology Society working group conference was supported by a grant from CBLPath Inc. Dr. Angelos and Dr. Zeiger reported having no disclosures.

sworcester@frontlinemedcom.com

Pages

Recommended Reading

VIDEO: Low thyroid function increases odds of type 2 diabetes
MDedge Endocrinology
Morning cortisol rules out adrenal insufficiency
MDedge Endocrinology
VIDEO: More routine use of unilateral thyroidectomy advocated for papillary thyroid microcarcinoma
MDedge Endocrinology
VIDEO: Proposed revision of medullary thyroid cancer staging improves risk-stratification analysis
MDedge Endocrinology
Negative sestamibi scan for primary hyperparathyroidism can mean no referral or surgery
MDedge Endocrinology
Post-parathyroidectomy follow-up may need to be open-ended
MDedge Endocrinology
Surgery has edge over surveillance for micropapillary thyroid cancer
MDedge Endocrinology
Surgery for PHPT improves sleep quality
MDedge Endocrinology
TSH antibody levels predict Graves relapse after thionamides
MDedge Endocrinology
Parathyroidectomy before kidney transplant may reduce complications
MDedge Endocrinology